论文信息 - A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma - 字舞流文

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

T. Habermann | P. L. Bergsagel | A. Dueck | D. Northfelt | C. Reeder | S. Ansell | T. Witzig | H. Kosiorek | D. Inwards | T. Hilal | J. Leis | C. Conley | C. Nichols | M. Sonbol | A. Rosenthal | K. Gano | B. Ginos | P. Johnston